OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia
Christopher J. Winrow, Anthony L. Gotter, Christopher D. Cox, et al.
Neuropharmacology (2011) Vol. 62, Iss. 2, pp. 978-987
Closed Access | Times Cited: 121
Christopher J. Winrow, Anthony L. Gotter, Christopher D. Cox, et al.
Neuropharmacology (2011) Vol. 62, Iss. 2, pp. 978-987
Closed Access | Times Cited: 121
Showing 26-50 of 121 citing articles:
Discovery of 5′′‐Chloro‐N‐[(5,6‐dimethoxypyridin‐2‐yl)methyl]‐2,2′:5′,3′′‐terpyridine‐3′‐carboxamide (MK‐1064): A Selective Orexin 2 Receptor Antagonist (2‐SORA) for the Treatment of Insomnia
Anthony J. Roecker, Swati P. Mercer, John D. Schreier, et al.
ChemMedChem (2013) Vol. 9, Iss. 2, pp. 311-322
Closed Access | Times Cited: 62
Anthony J. Roecker, Swati P. Mercer, John D. Schreier, et al.
ChemMedChem (2013) Vol. 9, Iss. 2, pp. 311-322
Closed Access | Times Cited: 62
Orexin/Hypocretin Based Pharmacotherapies for the Treatment of Addiction: DORA or SORA?
Shaun Yon‐Seng Khoo, Robyn M. Brown
CNS Drugs (2014) Vol. 28, Iss. 8, pp. 713-730
Open Access | Times Cited: 58
Shaun Yon‐Seng Khoo, Robyn M. Brown
CNS Drugs (2014) Vol. 28, Iss. 8, pp. 713-730
Open Access | Times Cited: 58
Effects of a newly developed potent orexin-2 receptor-selective antagonist, compound 1 m, on sleep/wakefulness states in mice
Keishi Etori, Yuki Saito, Natsuko Tsujino, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 53
Keishi Etori, Yuki Saito, Natsuko Tsujino, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 53
Targeted Orexin and Hypothalamic Neuropeptides for Migraine
Lauren C Strother, Anan Srikiatkhachorn, Weera Supronsinchai
Neurotherapeutics (2018) Vol. 15, Iss. 2, pp. 377-390
Open Access | Times Cited: 53
Lauren C Strother, Anan Srikiatkhachorn, Weera Supronsinchai
Neurotherapeutics (2018) Vol. 15, Iss. 2, pp. 377-390
Open Access | Times Cited: 53
Suvorexant for the treatment of insomnia
Laura H. Jacobson, Gabrielle E. Callander, Daniël Hoyer
Expert Review of Clinical Pharmacology (2014) Vol. 7, Iss. 6, pp. 711-730
Closed Access | Times Cited: 52
Laura H. Jacobson, Gabrielle E. Callander, Daniël Hoyer
Expert Review of Clinical Pharmacology (2014) Vol. 7, Iss. 6, pp. 711-730
Closed Access | Times Cited: 52
Orexin Signaling: A Complex, Multifaceted Process
Natasha C. Dale, Daniël Hoyer, Laura H. Jacobson, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 26
Natasha C. Dale, Daniël Hoyer, Laura H. Jacobson, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 26
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
Expression and purification of an activated Orexin receptor 1- G-protein complex
Ioanna Ramou, Steven Janvier, Sarah Druwé, et al.
Protein Expression and Purification (2025) Vol. 228, pp. 106660-106660
Closed Access
Ioanna Ramou, Steven Janvier, Sarah Druwé, et al.
Protein Expression and Purification (2025) Vol. 228, pp. 106660-106660
Closed Access
Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer’s disease and Parkinson’s disease: Therapeutic avenue of Dual OXR Antagonist (DORA)
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access
The dual orexin receptor antagonist almorexant, alone and in combination with morphine, cocaine and amphetamine, on conditioned place preference and locomotor sensitization in the rat
Michel A. Steiner, Hugues Lecourt, François Jenck
The International Journal of Neuropsychopharmacology (2012) Vol. 16, Iss. 2, pp. 417-432
Open Access | Times Cited: 50
Michel A. Steiner, Hugues Lecourt, François Jenck
The International Journal of Neuropsychopharmacology (2012) Vol. 16, Iss. 2, pp. 417-432
Open Access | Times Cited: 50
Systematic Approach to Conformational Sampling for Assigning Absolute Configuration Using Vibrational Circular Dichroism
Edward C. Sherer, Claire H. Lee, Joseph Shpungin, et al.
Journal of Medicinal Chemistry (2014) Vol. 57, Iss. 2, pp. 477-494
Closed Access | Times Cited: 44
Edward C. Sherer, Claire H. Lee, Joseph Shpungin, et al.
Journal of Medicinal Chemistry (2014) Vol. 57, Iss. 2, pp. 477-494
Closed Access | Times Cited: 44
Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators
Anthony L. Gotter, Susan L. Garson, Joanne Stevens, et al.
BMC Neuroscience (2014) Vol. 15, Iss. 1
Open Access | Times Cited: 42
Anthony L. Gotter, Susan L. Garson, Joanne Stevens, et al.
BMC Neuroscience (2014) Vol. 15, Iss. 1
Open Access | Times Cited: 42
Inhibition of Orexin Signaling Promotes Sleep Yet Preserves Salient Arousability in Monkeys
Pamela L. Tannenbaum, Spencer J. Tye, Joanne Stevens, et al.
SLEEP (2016) Vol. 39, Iss. 3, pp. 603-612
Open Access | Times Cited: 42
Pamela L. Tannenbaum, Spencer J. Tye, Joanne Stevens, et al.
SLEEP (2016) Vol. 39, Iss. 3, pp. 603-612
Open Access | Times Cited: 42
Orexin Receptor Antagonists and Insomnia
Xin Wu, Tao Xue, Zhouqing Chen, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 509-521
Closed Access | Times Cited: 20
Xin Wu, Tao Xue, Zhouqing Chen, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 509-521
Closed Access | Times Cited: 20
Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference
Jed Black, Giora Pillar, Jan Hedner, et al.
Sleep Medicine (2017) Vol. 36, pp. 86-94
Closed Access | Times Cited: 39
Jed Black, Giora Pillar, Jan Hedner, et al.
Sleep Medicine (2017) Vol. 36, pp. 86-94
Closed Access | Times Cited: 39
The hypocretin/orexin antagonist almorexant promotes sleep without impairment of performance in rats
Stephen R. Morairty, Alan J. Wilk, Webster U. Lincoln, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 37
Stephen R. Morairty, Alan J. Wilk, Webster U. Lincoln, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 37
A Phase II Dose-Ranging Study Evaluating the Efficacy and Safety of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Primary Insomnia
Kathryn M. Connor, Erin Mahoney, Saheeda Jackson, et al.
The International Journal of Neuropsychopharmacology (2016) Vol. 19, Iss. 8, pp. pyw022-pyw022
Open Access | Times Cited: 37
Kathryn M. Connor, Erin Mahoney, Saheeda Jackson, et al.
The International Journal of Neuropsychopharmacology (2016) Vol. 19, Iss. 8, pp. pyw022-pyw022
Open Access | Times Cited: 37
Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogs
Pamela L. Tannenbaum, Joanne Stevens, Jacquelyn Binns, et al.
Frontiers in Behavioral Neuroscience (2014) Vol. 8
Open Access | Times Cited: 36
Pamela L. Tannenbaum, Joanne Stevens, Jacquelyn Binns, et al.
Frontiers in Behavioral Neuroscience (2014) Vol. 8
Open Access | Times Cited: 36
Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review
Aisha S. Shariq, Joshua D. Rosenblat, Asem Alageel, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 92, pp. 1-7
Closed Access | Times Cited: 36
Aisha S. Shariq, Joshua D. Rosenblat, Asem Alageel, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 92, pp. 1-7
Closed Access | Times Cited: 36
Emerging role of orexin antagonists in insomnia therapeutics: An update on SORAs and DORAs
Anil Kumar, Priyanka Chanana, Supriti Choudhary
Pharmacological Reports (2015) Vol. 68, Iss. 2, pp. 231-242
Closed Access | Times Cited: 35
Anil Kumar, Priyanka Chanana, Supriti Choudhary
Pharmacological Reports (2015) Vol. 68, Iss. 2, pp. 231-242
Closed Access | Times Cited: 35
Pharmaco-EEG Studies in Animals: A History-Based Introduction to Contemporary Translational Applications
Wilhelmus Drinkenburg, A. Ahnaou, G.S.F. Ruigt
Neuropsychobiology (2015) Vol. 72, Iss. 3-4, pp. 139-150
Open Access | Times Cited: 35
Wilhelmus Drinkenburg, A. Ahnaou, G.S.F. Ruigt
Neuropsychobiology (2015) Vol. 72, Iss. 3-4, pp. 139-150
Open Access | Times Cited: 35
Orexin OX2 Receptor Antagonists as Sleep Aids
Laura H. Jacobson, Sui Chen, Sanjida Mir, et al.
Current topics in behavioral neurosciences (2016), pp. 105-136
Open Access | Times Cited: 35
Laura H. Jacobson, Sui Chen, Sanjida Mir, et al.
Current topics in behavioral neurosciences (2016), pp. 105-136
Open Access | Times Cited: 35
Hypnotics with novel modes of action
Daniël Hoyer, Andrew G. Allen, Laura H. Jacobson
British Journal of Clinical Pharmacology (2019) Vol. 86, Iss. 2, pp. 244-249
Open Access | Times Cited: 33
Daniël Hoyer, Andrew G. Allen, Laura H. Jacobson
British Journal of Clinical Pharmacology (2019) Vol. 86, Iss. 2, pp. 244-249
Open Access | Times Cited: 33
Optical probing of orexin/hypocretin receptor antagonists
Shi‐Bin Li, Natalie Nevárez, William J. Giardino, et al.
SLEEP (2018) Vol. 41, Iss. 10
Open Access | Times Cited: 32
Shi‐Bin Li, Natalie Nevárez, William J. Giardino, et al.
SLEEP (2018) Vol. 41, Iss. 10
Open Access | Times Cited: 32
Kinetic properties of “dual” orexin receptor antagonists at OX1R and OX2R orexin receptors
Gabrielle E. Callander, Morenike Olorunda, Dominique Monna, et al.
Frontiers in Neuroscience (2013) Vol. 7
Open Access | Times Cited: 35
Gabrielle E. Callander, Morenike Olorunda, Dominique Monna, et al.
Frontiers in Neuroscience (2013) Vol. 7
Open Access | Times Cited: 35
